Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 29–29 | Cite as

Rivaroxaban after PCI in AF: better outcomes, lower cost

Clinical study
  • 14 Downloads

Reference

  1. Korjian S, et al. Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). American Journal of Cardiology : 6 Nov 2018. Available from: URL: http://doi.org/10.1016/j.amjcard.2018.10.033

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations